Latest filing published 18 May 2015 for CERENOME, INC..
Insider track record
No signal scores available.
Closed purchases
Based on 10 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +16.2%Entry US$9,534,375.00 · Close at T+365 US$11,081,250.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Paul W. Hawran: trading record in brief
Paul W. Hawran is a declared insider at 3 companies; the most frequent names are Sequenom Inc, Neurocrine Biosciences Inc and Cerenome, Inc. In total, 83 filings cover trades dated from 17 May 2006 to 8 May 2015.
Market trades split into 51 purchases (€568k) and 20 sales (€1.8M). On balance, insiders were net sellers of €1.2M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 12 share grants.
The median purchase comes to €5,486. Ninety days after publication, 10 purchases show a median change of +33.7%, with the price up in 80% of them. They describe history only and say nothing certain about the share price ahead.
On 18 May 2015 came the latest disclosure, a share grant in Cerenome, Inc. The clock since the last published purchase (15 September 2011) now reads 5,533 days. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Paul W. Hawran
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 19,424 shares0Restricted Stock Award (Common Stock)SEC:0001140361-15-020705:0
- 5,862 shares0Restricted Stock Award (Common Stock)SEC:0001140361-14-022298:0
- 10,550 shares0Restricted Stock Award (Common Stock)SEC:0001140361-14-000459:0
- 6,100 shares0Restricted Stock Award (Common Stock)SEC:0001140361-13-000814:0
- 10,000 shares0Restricted Stock Award (Common Stock)SEC:0001140361-12-001029:0
- 3,000 shares@ US$3.18Common StockSEC:0001140361-11-045987:0Canonical exit: 13 Dec 2011 (T+90)
- 2,000 shares@ US$3.23Common StockSEC:0001140361-11-045987:1Canonical exit: 13 Dec 2011 (T+90)
- 6,000 shares0Restricted Stock Award (Common Stock)SEC:0001140361-11-000969:0
- 5,000 shares@ US$4.65Common StockSEC:0001140361-10-022777:0Canonical exit: 22 Aug 2010 (T+90)
- 5,000 shares@ US$4.83Common StockSEC:0001140361-10-022330:0Canonical exit: 17 Aug 2010 (T+90)
- 1,294 shares0Restricted Stock Award (Common Stock)SEC:0001140361-10-005399:0
- 5,000 shares@ US$4.90Common StockSEC:0001140361-09-027557:0Canonical exit: 23 Feb 2010 (T+90)
- 5,000 shares@ US$4.74Common StockSEC:0001140361-09-027438:0Canonical exit: 22 Feb 2010 (T+90)
- 10,000 shares@ US$4.24Common StockSEC:0001140361-09-026777:0Canonical exit: 16 Feb 2010 (T+90)
- 10,000 shares@ US$4.25Common StockSEC:0001140361-09-026777:1Canonical exit: 16 Feb 2010 (T+90)
- 5,000 shares@ US$3.98Common StockSEC:0001140361-09-026639:0Canonical exit: 15 Feb 2010 (T+90)
- 10,000 shares@ US$3.50Common StockSEC:0001140361-09-025788:0Canonical exit: 10 Feb 2010 (T+90)
- 4,316 shares0Restricted Stock Award (Common Stock)SEC:0001140361-09-010978:0
- 2,000 shares@ US$13.46Common StockSEC:0001329344-09-000032:0Canonical exit: 11 Jun 2009 (T+90)
- 5,000 shares@ US$13.45Common StockSEC:0001321466-09-000006:0Canonical exit: 2 Jun 2009 (T+90)
- 500 shares@ US$7.04Common StockSEC:0001209191-08-013529:0Canonical exit: 26 May 2008 (T+90)
- 300 shares@ US$7.08Common StockSEC:0001209191-08-013529:1Canonical exit: 26 May 2008 (T+90)
- 600 shares@ US$7.09Common StockSEC:0001209191-08-013529:2Canonical exit: 26 May 2008 (T+90)
- 127 shares@ US$7.10Common StockSEC:0001209191-08-013529:3Canonical exit: 26 May 2008 (T+90)
- 600 shares@ US$7.11Common StockSEC:0001209191-08-013529:4Canonical exit: 26 May 2008 (T+90)
25 of 79 declarations
